Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BSX compared with AZN: revenue, margins and what each company keeps, and the suppliers and customers both name
BSX
Boston Scientific Corp
Change
Mkt cap
Revenue
Revenue
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
BSX
Boston Scientific Corp
vs
AZN
Astrazeneca PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BSX
2 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 28 '26
±6.8%
▼
−5.84%
×0.85
Q2 FY26
±8.4%
▼
−0.04%
×0.00
Q1 FY26
±5.2%
▲
+8.99%
×1.73
Feb 4 '26
±4.5%
▼
−17.59%
×3.91
AZN
No earnings history for AZN.
= implied
BSX realized, solid
AZN realized, hatched
One scale, both sides: full bar = 18%
× = |realized| ÷ implied
Source: market data
BSX
Boston Scientific Corp
Change
44.33
· pre 44.09
· delayed
Mkt cap
$60.8B
Revenue
$5.1B
Q3 FY26
Revenue
$20.1B
FY25
AZN
Astrazeneca PLC
Change
186.61
· pre 187.50
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$289.4B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 3 '26
delayed
BSX
Boston Scientific Corp
vs
AZN
Astrazeneca PLC
44.33
pre 44.09
delayed
Price
186.61
pre 187.50
delayed
$60.8B
Mkt cap
$289.4B
Q3 FY26
$5.1B
Revenue
—
FY25
$20.1B
Revenue
—
Change
Change
BSX
44.33
vs
AZN
186.61
Pre-market
Nov 3 '26
delayed